Department of Clinical Pharmacology, Medical University of Vienna
Vienna, 1090, Austria
NCT Number: NCT03401892
Ischemic optic neuropathy is among the most common causes of serious impaired vision in the middle-aged and elderly population in the western world. The current study focuses on a subgroup of ischemic optic neuropathy, the so-called non-arteritic ischemic optic neuropathy (NAION). Although the exact pathogenesis of NAION has not been fully clarified it is known that patients with cardio-vascular risk factors such as hypertension, diabetes mellitus and dyslipidemia have also an increased risk to develop NAION. Along this line of thought it has been shown that patients with a history of NAION in one eye have an increased risk to develop NAION also on the contralateral eye. However, clinical studies investigating ocular perfusion abnormalities in patients with NAION are sparse and even contradicting. Thus, the current study seeks to measure ocular blood flow parameters in patients with a history of NAION and compare it to healthy age-matched subjects.
Looking for future studies?
Notify Me18 year and older
All sexes
Interventional
Not applicable
Vienna, 1090, Austria
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
for healthy subjects:
Inclusion criteria
for patients with NAION:
Any of the following will exclude a healthy subject from the study:
Any of the following will exclude a patient from the study:
Retinal vessel diameters and oxygen saturation will be measured with the DVA device.
Retinal blood flow will be assessed using FDOCT.
Nerve fiber layer thickness and central retinal thickness will be measured using OCT.
Time frame: 1 day
Response of retinal vessels to increased neuronal activity assessed with flicker light
Time frame: 1 day
Response of retinal vessel diameters to flicker light assessed with DVA
Time frame: 1 day
Retinal oxygen saturation measured with DVA
Time frame: 1 day
Response of retinal blood flow to flicker light assessed with FDOCT
Time frame: 1 day
Retinal nerve fiber layer thickness measured using OCT
Time frame: 1 day
Central retinal thickness using OCT
Medical University of Vienna
Other
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT01260324
Anterior Ischemic Optic Neuropathy, Cardiovascular Diseases
View Trial DetailsNCT05749094
Anterior Ischemic Optic Neuropathy, Arteritis
London, Ontario, Canada
View Trial DetailsNCT06500728
Anterior Ischemic Optic Neuropathy, Arterial Occlusive Diseases
Milan, Lombardy, Italy
View Trial DetailsNCT07330713
Cardiovascular Diseases, Cranial Nerve Diseases
Bursa, Turkey (Türkiye)
View Trial Details